Eidogen-Sertanty Licenses Discovery Informatics Software and Databases to Cephalon
News Jan 06, 2006
Eidogen-Sertanty, Inc. has announced that Cephalon, Inc. will access Eidogen-Sertanty's Kinase Knowledgebase (KKB™), Target Informatics Platform™ (TIP™), and EVE™ Comparative Visualization software.
Scientists at Cephalon will use the proprietary software to support small molecule drug discovery projects in their neurology and oncology therapeutic programs.
"We are pleased to provide Cephalon with broad access to several of our discovery informatics products," said Dr. Steve Muskal, CEO of Eidogen-Sertanty.
"We're confident that our kinase informatics and structural informatics solutions will help the experienced research team at Cephalon accelerate their lead discovery efforts."
Old age is the greatest risk factor for many diseases, including Alzheimer's disease (AD) and cancer. Geroprotectors are a recently identified class of anti-aging compounds. New research has now identified a unique subclass of these compounds, dubbed geroneuroprotectors (GNPs), which are AD drug candidates and slow the aging process in mice.READ MORE